carbamazepine has been researched along with Drug Refractory Epilepsy in 33 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Excerpt | Relevance | Reference |
---|---|---|
"Gabapentin as monotherapy probably controlled seizures no better and no worse than comparator AEDs (lamotrigine, carbamazepine, oxcarbazepine, and topiramate)." | 9.41 | Gabapentin monotherapy for epilepsy: A review. ( Abakumova, T; Hoyle, CHV; Ziganshina, LE, 2023) |
" The efficacy evaluation of NPs/KCZ was evaluated in a kainic acid (KA)-induced mice model of epilepsy with carbamazepine (CBZ) treatment." | 8.12 | Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy. ( Fu, J; Lv, K; Sun, W; Wang, J; Yin, X; Zhang, J, 2022) |
"Epigenetics underlying refractory epilepsy is poorly understood." | 5.51 | Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. ( Cui, L; Lv, Y; Shi, M; Wang, Z; Zheng, X, 2019) |
"Gabapentin as monotherapy probably controlled seizures no better and no worse than comparator AEDs (lamotrigine, carbamazepine, oxcarbazepine, and topiramate)." | 5.41 | Gabapentin monotherapy for epilepsy: A review. ( Abakumova, T; Hoyle, CHV; Ziganshina, LE, 2023) |
"In adults with focal seizures, adjunctive BRV treatment does not affect plasma concentrations of the evaluated AEDs but increases carbamazepine epoxide metabolite." | 5.30 | Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials. ( Moseley, BD; Otoul, C; Staelens, L; Stockis, A, 2019) |
"The gene polymorphisms of ABCB1, EPHX1, and SCN1A were found to influence carbamazepine (CBZ) metabolism and resistance in epilepsy patients, but the relevance remains controversial." | 5.12 | ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients. ( Bai, ZF; Chen, XF; Chen, XL; Li, WX; Tang, JF; Wang, XY; Xiao, XH; Zhang, H; Zhang, ML; Zhang, SQ; Zhao, X; Zhao, YL, 2021) |
" The point estimates of carbamazepine and lamotrigine efficacy showed their superiority with respect to all comparator antiepileptic drugs for the treatment of newly diagnosed focal epilepsy." | 4.98 | Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis. ( Crescioli, G; De Masi, S; Guerrini, R; Ilvento, L; Lucenteforte, E; McGreevy, KS; Mugelli, A; Pugi, A; Rosati, A; Virgili, G, 2018) |
"The purpose of this study was to detect the changes of P-Glycoprotein (P-GP) expression in rat brain microvessel endothelial cell line RBE4 after the action of Tetramethylpyrazine (TMP) on Carbamazepine (CBZ), so as to clarify the potential mechanism of TMP combined with CBZ against intractable epilepsy drug resistance." | 4.31 | Study on the reversal of epileptic drug resistance by tetramethylpyrazine in combination with carbamazepine through modulation of P-Glycoprotein expression in rat brain microvessel endothelial cell. ( Deng, Y; Li, Y; Liu, J; Liu, W; Qian, X; Wang, J; Xiao, G; Yan, J; Ye, J; Zhong, N, 2023) |
" The efficacy evaluation of NPs/KCZ was evaluated in a kainic acid (KA)-induced mice model of epilepsy with carbamazepine (CBZ) treatment." | 4.12 | Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy. ( Fu, J; Lv, K; Sun, W; Wang, J; Yin, X; Zhang, J, 2022) |
" There were no notable differences in overall tolerability between subgroups, but the incidence of some adverse events (eg, dizziness, somnolence, nausea) differed between subgroups and/or between treatment periods." | 2.87 | Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine. ( Blum, D; Cheng, H; Grinnell, T; Harvey, JH; Pazdera, L; Sam, MC; Sperling, MR; Strom, LA, 2018) |
"Data on epilepsy syndrome, duration, seizure types, concomitant and previous antiseizure medication (ASM) use, BRV dosing, efficacy, and side effects were recorded." | 1.72 | Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center. ( Green, SF; Hare, N; Kassam, M; Koepp, MJ; Rajakulendran, S; Rugg-Gunn, F; Sander, JW, 2022) |
"Perampanel (PER) is a new antiepileptic drug (AED) with a novel mechanism of action." | 1.51 | Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy. ( Ishikawa, N; Kobayashi, M; Kobayashi, Y; Tani, H; Tateishi, Y, 2019) |
"Epigenetics underlying refractory epilepsy is poorly understood." | 1.51 | Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population. ( Cui, L; Lv, Y; Shi, M; Wang, Z; Zheng, X, 2019) |
"Conclusions Depressive disorders are common, underdiagnosed and undertreated in patients with refractory MTLE." | 1.48 | Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy. ( Cendes, F; de Oliveira Cardoso, TAM; Gonçalves, EB; Yasuda, CL, 2018) |
"Nocturnal frontal lobe epilepsy (NFLE) is an idiopathic partial epilepsy with a family history in about 25% of cases, with autosomal dominant inheritance (autosomal dominant NFLE [ADNFLE])." | 1.46 | Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy. ( Aroni, S; Marrosu, F; Melis, M; Milioli, G; Muntoni, AL; Parrino, L; Pillolla, G; Pistis, M; Puligheddu, M; Sagheddu, C; Terzano, GM, 2017) |
" Patients were switched because they experienced persistent seizures with OXC but were unable to tolerate increased OXC dosing due to adverse events." | 1.46 | Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study. ( Höfler, J; Kalss, G; Kirschner, M; Kuchukhidze, G; Leitinger, M; Rohracher, A; Schmid, E; Steinhoff, BJ; Trinka, E; Wendling, AS, 2017) |
"Seven (10." | 1.46 | Drug-resistant epilepsy in children with partial onset epilepsy treated with carbamazepine. ( Aungaroon, G; Holland, KD; Horn, PS; Imming, CM; Standridge, SM, 2017) |
" We sought to determine whether there were regions in the dosage range of commonly used AEDs that were associated with superior efficacy in patients with refractory epilepsy." | 1.46 | Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy. ( Castagna, CE; Miller, AB; Poolos, NP; Story, TJ; Williams, S, 2017) |
"Adolescents with pharmacologically intractable epilepsy had lower lexical fluency scores than healthy peers, but did not differ from them on the dimensions of lexical breadth and lexical depth." | 1.43 | Lexicon before and after epilepsy surgery in adolescents. ( Braams, OB; Braun, KP; Chanturidze, M; Hendriks, MP; Jennekens-Schinkel, A; Meekes, J; van Nieuwenhuizen, O; van Rijen, PC, 2016) |
"Daytime somnolence was reported by 28 patients, 15 on OXC (10%); 8 received oral modafinil for the same, while none discontinued this AED." | 1.43 | Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy. ( Agarwal, P; Gupta, A; Poornima, S; Shukla, G, 2016) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 23 (69.70) | 24.3611 |
2020's | 10 (30.30) | 2.80 |
Authors | Studies |
---|---|
Green, SF | 1 |
Hare, N | 1 |
Kassam, M | 1 |
Rugg-Gunn, F | 1 |
Koepp, MJ | 2 |
Sander, JW | 2 |
Rajakulendran, S | 1 |
Wang, J | 2 |
Fu, J | 1 |
Sun, W | 1 |
Yin, X | 1 |
Lv, K | 1 |
Zhang, J | 1 |
Ziganshina, LE | 1 |
Abakumova, T | 1 |
Hoyle, CHV | 1 |
Qian, X | 1 |
Deng, Y | 1 |
Zhong, N | 1 |
Li, Y | 1 |
Yan, J | 1 |
Liu, W | 1 |
Ye, J | 1 |
Liu, J | 1 |
Xiao, G | 1 |
Zavala-Tecuapetla, C | 1 |
Orozco-Suarez, S | 1 |
Manjarrez, J | 1 |
Cuellar-Herrera, M | 1 |
Vega-Garcia, A | 1 |
Buzoianu-Anguiano, V | 1 |
Moseley, BD | 1 |
Otoul, C | 1 |
Staelens, L | 1 |
Stockis, A | 1 |
Yamamoto, A | 1 |
Saito, Y | 1 |
Oyama, Y | 1 |
Watanabe, Y | 1 |
Ikeda, A | 1 |
Takayama, R | 1 |
Ikeda, H | 1 |
Takeshita, S | 1 |
Takumi, I | 1 |
Itai, T | 1 |
Miyatake, S | 1 |
Matsumoto, N | 1 |
Koneval, Z | 1 |
Knox, KM | 1 |
Memon, A | 1 |
Zierath, DK | 1 |
White, HS | 1 |
Barker-Haliski, M | 1 |
Quon, RJ | 1 |
Meisenhelter, S | 1 |
Adamovich-Zeitlin, RH | 1 |
Song, Y | 1 |
Steimel, SA | 1 |
Camp, EJ | 1 |
Testorf, ME | 1 |
MacKenzie, TA | 1 |
Gross, RE | 1 |
Lega, BC | 1 |
Sperling, MR | 2 |
Kahana, MJ | 1 |
Jobst, BC | 1 |
Cho, SJ | 1 |
Park, E | 1 |
Baker, A | 1 |
Reid, AY | 1 |
Zhang, ML | 1 |
Chen, XL | 1 |
Bai, ZF | 1 |
Zhao, X | 1 |
Li, WX | 1 |
Wang, XY | 1 |
Zhang, H | 1 |
Chen, XF | 1 |
Zhang, SQ | 1 |
Tang, JF | 1 |
Xiao, XH | 1 |
Zhao, YL | 1 |
Puligheddu, M | 1 |
Melis, M | 1 |
Pillolla, G | 1 |
Milioli, G | 1 |
Parrino, L | 1 |
Terzano, GM | 1 |
Aroni, S | 1 |
Sagheddu, C | 1 |
Marrosu, F | 1 |
Pistis, M | 1 |
Muntoni, AL | 1 |
Shakir, S | 1 |
Ali, N | 1 |
Udin, Z | 1 |
Nazish, H | 1 |
Nabi, M | 1 |
Kheloufi, F | 1 |
Default, A | 1 |
Perrouty, B | 1 |
Blin, O | 1 |
Micallef, J | 1 |
Gonçalves, EB | 1 |
de Oliveira Cardoso, TAM | 1 |
Yasuda, CL | 1 |
Cendes, F | 1 |
Rosati, A | 1 |
Ilvento, L | 1 |
Lucenteforte, E | 1 |
Pugi, A | 1 |
Crescioli, G | 1 |
McGreevy, KS | 1 |
Virgili, G | 1 |
Mugelli, A | 1 |
De Masi, S | 1 |
Guerrini, R | 1 |
Pazdera, L | 1 |
Harvey, JH | 1 |
Sam, MC | 1 |
Strom, LA | 1 |
Blum, D | 1 |
Grinnell, T | 1 |
Cheng, H | 1 |
Zybina, A | 1 |
Anshakova, A | 1 |
Malinovskaya, J | 1 |
Melnikov, P | 1 |
Baklaushev, V | 1 |
Chekhonin, V | 1 |
Maksimenko, O | 1 |
Titov, S | 1 |
Balabanyan, V | 1 |
Kreuter, J | 1 |
Gelperina, S | 1 |
Abbasova, K | 1 |
Beckonert, NM | 1 |
Opitz, T | 1 |
Pitsch, J | 1 |
Soares da Silva, P | 1 |
Beck, H | 1 |
Xiao, F | 1 |
Caciagli, L | 1 |
Wandschneider, B | 1 |
Sidhu, M | 1 |
Winston, G | 1 |
Burdett, J | 1 |
Trimmel, K | 1 |
Hill, A | 1 |
Vollmar, C | 1 |
Vos, SB | 1 |
Ourselin, S | 1 |
Thompson, PJ | 1 |
Zhou, D | 1 |
Duncan, JS | 1 |
Huang, Q | 1 |
Yu, L | 1 |
Ma, M | 1 |
Qi, H | 1 |
Wu, Y | 1 |
Ishikawa, N | 1 |
Tateishi, Y | 1 |
Tani, H | 1 |
Kobayashi, Y | 1 |
Kobayashi, M | 1 |
Lv, Y | 1 |
Zheng, X | 1 |
Shi, M | 1 |
Wang, Z | 1 |
Cui, L | 1 |
Mateo-Carrasco, H | 1 |
Serrano-Castro, PJ | 1 |
Molina-Cuadrado, E | 1 |
Goodwin, M | 1 |
Nguyen, TV | 1 |
Kotecha, PN | 1 |
Meekes, J | 1 |
Chanturidze, M | 1 |
Braams, OB | 1 |
Braun, KP | 1 |
van Rijen, PC | 1 |
Hendriks, MP | 1 |
Jennekens-Schinkel, A | 1 |
van Nieuwenhuizen, O | 1 |
Klaft, ZJ | 1 |
Hollnagel, JO | 1 |
Salar, S | 1 |
Calişkan, G | 1 |
Schulz, SB | 1 |
Schneider, UC | 1 |
Horn, P | 1 |
Koch, A | 1 |
Holtkamp, M | 1 |
Gabriel, S | 1 |
Gerevich, Z | 1 |
Heinemann, U | 1 |
Cappaert, NL | 1 |
Werkman, TR | 1 |
Benito, N | 1 |
Witter, MP | 1 |
Baayen, JC | 1 |
Wadman, WJ | 1 |
Schmid, E | 1 |
Kuchukhidze, G | 1 |
Kirschner, M | 1 |
Leitinger, M | 1 |
Höfler, J | 1 |
Rohracher, A | 1 |
Kalss, G | 1 |
Wendling, AS | 1 |
Steinhoff, BJ | 1 |
Trinka, E | 1 |
Fallah, A | 1 |
Weil, AG | 1 |
Wang, S | 1 |
Lewis, E | 1 |
Baca, CB | 1 |
Mathern, GW | 1 |
Shukla, G | 1 |
Gupta, A | 1 |
Agarwal, P | 1 |
Poornima, S | 1 |
Aungaroon, G | 1 |
Holland, KD | 1 |
Horn, PS | 1 |
Standridge, SM | 1 |
Imming, CM | 1 |
Tarnutzer, AA | 1 |
Imbach, LL | 1 |
Poolos, NP | 1 |
Castagna, CE | 1 |
Williams, S | 1 |
Miller, AB | 1 |
Story, TJ | 1 |
4 reviews available for carbamazepine and Drug Refractory Epilepsy
Article | Year |
---|---|
Gabapentin monotherapy for epilepsy: A review.
Topics: Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Epilepsies, Partial; Epilepsy; Gabapentin; | 2023 |
ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
Topics: Adult; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transpor | 2021 |
Comparative efficacy of antiepileptic drugs in children and adolescents: A network meta-analysis.
Topics: Adolescent; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anticonvulsants; Carbamazepine; Ch | 2018 |
Role of high-dose levetiracetam as add-on therapy for intractable epilepsy: case report and brief review of the literature.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Drug Synergism; Drug Therapy, Combin | 2015 |
3 trials available for carbamazepine and Drug Refractory Epilepsy
Article | Year |
---|---|
Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Epilepsies, Partial; Female; Humans; | 2019 |
Efficacy and safety of eslicarbazepine acetate monotherapy in patients converting from carbamazepine.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Resistant Epilepsy; Dr | 2018 |
Effects of carbamazepine and lamotrigine on functional magnetic resonance imaging cognitive networks.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Brain; Carbamazepine; Cognition; Dose-Response Relationshi | 2018 |
26 other studies available for carbamazepine and Drug Refractory Epilepsy
Article | Year |
---|---|
Retention of brivaracetam in adults with drug-resistant epilepsy at a single tertiary care center.
Topics: Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Drug Therapy, Combination; Drug-Related Sid | 2022 |
Functionalized PEG-PLA nanoparticles for brain targeted delivery of ketoconazole contribute to pregnane X receptor overexpressing in drug-resistant epilepsy.
Topics: Animals; Brain; Carbamazepine; Drug Resistant Epilepsy; Epilepsy; Kainic Acid; Ketoconazole; Mice; M | 2022 |
Study on the reversal of epileptic drug resistance by tetramethylpyrazine in combination with carbamazepine through modulation of P-Glycoprotein expression in rat brain microvessel endothelial cell.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily | 2023 |
Activation of adenosine receptors modulates the efflux transporters in brain capillaries and restores the anticonvulsant effect of carbamazepine in carbamazepine resistant rats developed by window-pentylenetetrazole kindling.
Topics: Animals; Anticonvulsants; Brain; Capillaries; Carbamazepine; Disease Models, Animal; Drug Resistant | 2020 |
Effect of total callosotomy on KCNQ2-related intractable epilepsy.
Topics: Carbamazepine; Child; Corpus Callosum; Drug Resistant Epilepsy; Electroencephalography; Female; Huma | 2020 |
Antiseizure drug efficacy and tolerability in established and novel drug discovery seizure models in outbred vs inbred mice.
Topics: Animals; Animals, Outbred Strains; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Cornea; | 2020 |
Factors correlated with intracranial interictal epileptiform discharges in refractory epilepsy.
Topics: Adult; Anticonvulsants; Attention; Carbamazepine; Drug Resistant Epilepsy; Electrocorticography; Fem | 2021 |
Post-Traumatic Epilepsy in Zebrafish Is Drug-Resistant and Impairs Cognitive Function.
Topics: Animals; Anticonvulsants; Carbamazepine; Cognitive Dysfunction; Disease Models, Animal; Drug Resista | 2021 |
Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy.
Topics: Adult; Animals; Anticonvulsants; Benzodiazepines; Carbamazepine; Clobazam; Disease Models, Animal; D | 2017 |
Vitamin B
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistant Epilepsy; | 2017 |
Perampanel-associated self-harm ideation after dosage increase.
Topics: Adult; Anticonvulsants; Carbamazepine; Drug Resistant Epilepsy; Drug Therapy, Combination; Epilepsie | 2018 |
Depressive disorders in patients with pharmaco-resistant mesial temporal lobe epilepsy.
Topics: Adult; Anticonvulsants; Antidepressive Agents; Benzodiazepines; Carbamazepine; Clobazam; Depressive | 2018 |
Nanoparticle-based delivery of carbamazepine: A promising approach for the treatment of refractory epilepsy.
Topics: Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Carbamazep | 2018 |
Polyamine Modulation of Anticonvulsant Drug Response: A Potential Mechanism Contributing to Pharmacoresistance in Chronic Epilepsy.
Topics: Animals; Anticonvulsants; Biogenic Polyamines; Carbamazepine; Drug Resistance; Drug Resistant Epilep | 2018 |
Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Disease Progression; Drug Resistant Epilepsy; Electro | 2019 |
Clinical profiles associated with serum perampanel concentrations in children with refractory epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Dizziness; Drug Resistant Epile | 2019 |
Different EPHX1 methylation levels in promoter area between carbamazepine-resistant epilepsy group and carbamazepine-sensitive epilepsy group in Chinese population.
Topics: Adult; Anticonvulsants; Asian People; Carbamazepine; DNA Methylation; Drug Resistance; Drug Resistan | 2019 |
Lexicon before and after epilepsy surgery in adolescents.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Cognition Disorders; Drug Resistant Epilepsy; Fem | 2016 |
Adenosine A1 receptor-mediated suppression of carbamazepine-resistant seizure-like events in human neocortical slices.
Topics: Adenosine; Adenosine Triphosphate; Adult; Bicuculline; Carbamazepine; Drug Resistant Epilepsy; Elect | 2016 |
Carbamazepine modulates the spatiotemporal activity in the dentate gyrus of rats and pharmacoresistant humans in vitro.
Topics: Adolescent; Adult; Animals; Anticonvulsants; Carbamazepine; Dentate Gyrus; Drug Resistant Epilepsy; | 2016 |
Overnight switching from oxcarbazepine to eslicarbazepine acetate: an observational study.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Dibenzazepines; Drug Resistant Epilepsy; Drug Substitut | 2017 |
Cost-utility analysis of competing treatment strategies for drug-resistant epilepsy in children with Tuberous Sclerosis Complex.
Topics: Anticonvulsants; Carbamazepine; Child; Cost-Benefit Analysis; Diet, Ketogenic; Drug Resistant Epilep | 2016 |
Behavioral effects and somnolence due to levetiracetam versus oxcarbazepine - a retrospective comparison study of North Indian patients with refractory epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Child; Disorders of Excessive Somnolence; Drug Re | 2016 |
Drug-resistant epilepsy in children with partial onset epilepsy treated with carbamazepine.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Child, Preschool; Drug Resistant Epilepsy; Epilep | 2017 |
The intoxicated EEG.
Topics: Adult; Anticonvulsants; Brain; Carbamazepine; Drug Overdose; Drug Resistant Epilepsy; Electroencepha | 2017 |
Association between antiepileptic drug dose and long-term response in patients with refractory epilepsy.
Topics: Adult; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Administration Schedul | 2017 |